NCT00739973 - Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension | Biotech Hunter

Enrollment

2,694

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions

Hypertension

Interventions

DRUG

Placebo

DRUG

Aliskiren 150 mg tablet

DRUG

Aliskiren 300 mg tablet

DRUG

Amlodipine 5 mg capsule

DRUG

Amlodipine 10 mg capsule

DRUG

Aliskiren/amlodipine 150/5 mg tablet

DRUG

Aliskiren/amlodipine 150/10 mg tablet

DRUG

Aliskiren/amlodipine 300/5 mg tablet

DRUG

Aliskiren/amlodipine 300/10 mg tablet

Trial Locations (18)

Unknown

Investigative Site, East Hanover

Investigative Site, Buenos Aires

Invesigative Site, Canberra

Investigative Site, Toronto

Investigative Site, Bogotá

Investigative Site, Copenhagen

Investigative Site, Oslo

Investigative Site, Athens

Investigative Site, Rome

Investigative Site, Mexico City

Investigative Site, Panama City

Investigative Site, Lima

Investigative Site, Bucharest

Investigative Site, Moscow

Investigative Site, Pretoria

Investigative Site, Madrid

Investigative Site, Stockholm

Investigative Site, Taipei